Atrial Fibrillation

Atrial Fibrillation (AFib) is common, with a 1 in 4 lifetime risk after age 40. AFib symptoms include fatigue, dizziness, activity intolerance, shortness of breath, and inability to perform activities of daily living. The stagnation of blood increases the risk of thromboembolism and stroke.  

A recent estimate found the number of individuals with AFib was over 33 million and is on the rise. Future projections predict at least five million new cases annually worldwide, with the prevalence in the US cases expected to reach up to 6.7 million by 2050. 

AFib management is not a one-size-fits-all approach, and healthcare providers need to be informed to follow guideline-recommended treatments for patients with AFib.